These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 31655620

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ, Kim HJ, Won JH, Lee SC, Chang AR.
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [Abstract] [Full Text] [Related]

  • 23. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions.
    Nelson JW, Yoo DS, Sampson JH, Isaacs RE, Larrier NA, Marks LB, Yin FF, Wu QJ, Wang Z, Kirkpatrick JP.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1369-75. PubMed ID: 19004569
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X, Gui C, Grimm J, Huang E, Kleinberg L, Lo L, Sciubba D, Khan M, Redmond KJ.
    Radiother Oncol; 2020 Sep 01; 150():142-149. PubMed ID: 32540335
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of a dedicated software for semi-automated VMAT planning of spine Stereotactic Body Radiotherapy (SBRT).
    Dupuis P, François M, Baudier T, Sunyach MP, Brahmi T, Ayadi M, Biston MC.
    Phys Med; 2023 May 01; 109():102578. PubMed ID: 37084679
    [Abstract] [Full Text] [Related]

  • 28. Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.
    Mazzola R, Cuccia F, Figlia V, Rigo M, Nicosia L, Giaj-Levra N, Ricchetti F, Vitale C, Mantoan B, Di Paola G, De Simone A, Gurrera D, Sicignano G, Naccarato S, Ruggieri R, Alongi F.
    Radiol Med; 2021 Jul 01; 126(7):989-997. PubMed ID: 33835309
    [Abstract] [Full Text] [Related]

  • 29. Superior target delineation for stereotactic body radiotherapy of bone metastases from renal cell carcinoma on MRI compared to CT.
    Prins FM, van der Velden JM, Gerlich AS, Kotte ANTJ, Eppinga WSC, Kasperts N, Verlaan JJ, Pameijer FA, Kerkmeijer LGW.
    Ann Palliat Med; 2017 Dec 01; 6(Suppl 2):S147-S154. PubMed ID: 28866897
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
    Cunha MV, Al-Omair A, Atenafu EG, Masucci GL, Letourneau D, Korol R, Yu E, Howard P, Lochray F, da Costa LB, Fehlings MG, Sahgal A.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):e343-9. PubMed ID: 22658511
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
    Gong Y, Xu L, Zhuang H, Jiang L, Wei F, Liu Z, Li Y, Yu M, Ni K, Liu X.
    Cancer Med; 2019 Oct 01; 8(14):6176-6184. PubMed ID: 31489788
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.
    Lubgan D, Ziegaus A, Semrau S, Lambrecht U, Lettmaier S, Fietkau R.
    Strahlenther Onkol; 2015 Mar 01; 191(3):264-71. PubMed ID: 25395089
    [Abstract] [Full Text] [Related]

  • 36. Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.
    Garg AK, Shiu AS, Yang J, Wang XS, Allen P, Brown BW, Grossman P, Frija EK, McAleer MF, Azeem S, Brown PD, Rhines LD, Chang EL.
    Cancer; 2012 Oct 15; 118(20):5069-77. PubMed ID: 22511344
    [Abstract] [Full Text] [Related]

  • 37. Postoperative stereotactic body radiotherapy for spinal metastases.
    Alghamdi M, Tseng CL, Myrehaug S, Maralani P, Heyn C, Soliman H, Lee Y, Ruschin M, Da Costa L, Yang V, Campbell M, Sahgal A.
    Chin Clin Oncol; 2017 Sep 15; 6(Suppl 2):S18. PubMed ID: 28917256
    [Abstract] [Full Text] [Related]

  • 38. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
    Redmond KJ, Lo SS, Soltys SG, Yamada Y, Barani IJ, Brown PD, Chang EL, Gerszten PC, Chao ST, Amdur RJ, De Salles AA, Guckenberger M, Teh BS, Sheehan J, Kersh CR, Fehlings MG, Sohn MJ, Chang UK, Ryu S, Gibbs IC, Sahgal A.
    J Neurosurg Spine; 2017 Mar 15; 26(3):299-306. PubMed ID: 27834628
    [Abstract] [Full Text] [Related]

  • 39. Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
    Roesch J, Cho JBC, Fahim DK, Gerszten PC, Flickinger JC, Grills IS, Jawad M, Kersh R, Letourneau D, Mantel F, Sahgal A, Shin JH, Winey B, Guckenberger M.
    Radiat Oncol; 2017 Sep 11; 12(1):153. PubMed ID: 28893299
    [Abstract] [Full Text] [Related]

  • 40. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
    Silva SR, Gliniewicz A, Martin B, Prabhu VC, Germanwala AV, Melian E, Jones GA, Solanki AA.
    World Neurosurg; 2019 Feb 11; 122():e342-e348. PubMed ID: 30326310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.